Lipocine to present at 36th annual roth conference

Salt lake city , march 6, 2024 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a biopharmaceutical company focused on treating central nervous system (cns) disorders, today announced that dr. mahesh v. patel, president and chief executive officer, will participate in a fireside chat and meet with investors at the 36th annual roth conference, to take place in laguna niguel, ca, on march 18.

LPCN Ratings Summary

LPCN Quant Ranking